Mounjaro enhances glucose-dependent insulin secretion from pancreatic beta cells, meaning it stimulates insulin release only when blood glucose levels are elevated, thereby reducing hypoglycaemia risk
Regulatory oversight is minimal in most jurisdictions, and compounded peptide sources lack standardized quality assurance comparable to FDA-regulated pharmaceuticals
Lee CH, Yan B, Yoo KY, Choi JH, Kwon SH, Her S, Sohn Y, Hwang IK, Cho JH, Kim YM, et al
To minimize the risk of complications, always follow the aftercare instructions provided by your healthcare professional and report any unusual symptoms promptly